Clinical Researcher—April 2021 (Volume 35, Issue 3) PEER REVIEWED Christina Morris; Erika Stevens, MA Biotechnology, medical device, and pharmaceutical companies are seeking other industries’ disruptive digital technologies to aid […]
Clinical Researcher—April 2021 (Volume 35, Issue 3) GOOD MANAGEMENT PRACTICE Scott Gray It's no secret that patient diversity is a major issue in clinical trials, and that a lack […]
Clinical Researcher—April 2021 (Volume 35, Issue 3) SITES & SPONSORS Mark Clements, MD, PhD, CPI, FAAP; Komathi Stem, MS COVID-19’s effect on clinical trials is a tale of two […]
Clinical Researcher—April 2021 (Volume 35, Issue 3) EXECUTIVE DIRECTOR’S MESSAGE Jim Kremidas Tuskegee. Henrietta Lacks. Project MKUltra. These and other names associated with reprehensible blemishes in medical research history […]
Clinical Researcher—April 2021 (Volume 35, Issue 3) THE LEGAL LANDSCAPE Robert King Medical researchers are not supposed to be motivated by the prospect of profit, but we all have […]